These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22321008)

  • 1. Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy.
    Cheng JW; Cheng SW; Yu DY; Wei RL; Lu GC
    Curr Med Res Opin; 2012 Apr; 28(4):543-50. PubMed ID: 22321008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs.
    Tanna AP; Rademaker AW; Stewart WC; Feldman RM
    Arch Ophthalmol; 2010 Jul; 128(7):825-33. PubMed ID: 20625041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
    Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC;
    Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
    Katz G; Dubiner H; Samples J; Vold S; Sall K
    JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.
    van der Valk R; Webers CA; Schouten JS; Zeegers MP; Hendrikse F; Prins MH
    Ophthalmology; 2005 Jul; 112(7):1177-85. PubMed ID: 15921747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure-lowering effect of adding dorzolamide or latanoprost to timolol: a meta-analysis of randomized clinical trials.
    Webers CA; van der Valk R; Schouten JS; Zeegers MP; Prins MH; Hendrikse F
    Ophthalmology; 2007 Jan; 114(1):40-6. PubMed ID: 17070584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma.
    Centofanti M; Manni G; Gregori D; Cocco F; Lorenzano D; Bucci MG
    Graefes Arch Clin Exp Ophthalmol; 2000 Apr; 238(4):302-5. PubMed ID: 10853928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-life experience of using brinzolamide/brimonidine fixed drop combination in a tertiary glaucoma centre.
    Kóthy P; Holló G
    Int Ophthalmol; 2020 Feb; 40(2):377-383. PubMed ID: 31650353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension.
    Cvetkovic RS; Perry CM
    Drugs Aging; 2003; 20(12):919-47. PubMed ID: 14565787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of intraocular pressure-lowering effects of adjunctive medications added to latanoprost.
    Cheng JW; Li Y; Wei RL
    Ophthalmic Res; 2009; 42(2):99-105. PubMed ID: 19546601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the European Glaucoma Prevention Study.
    Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
    Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Decrease in intraocular pressure following administration of the local carbonic anhydrase inhibitor (MK-927)--comparison of the effect with pilocarpine].
    Pfeiffer N; Grehn F; Hennekes R; Garus H
    Fortschr Ophthalmol; 1990; 87(2):128-30. PubMed ID: 2192972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study.
    Francis BA; Du LT; Berke S; Ehrenhaus M; Minckler DS;
    J Clin Pharm Ther; 2004 Aug; 29(4):375-80. PubMed ID: 15271105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of fixed combination of brimonidine 0.2%/timolol 0.5% compared with fixed combination of dorzolamide 2%/timolol 0.5% in the treatment of patients with elevated intraocular pressure: a meta-analysis of randomized controlled trials.
    Budengeri P; Cheng JW; Cai JP; Wei RL
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):474-9. PubMed ID: 23379771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intraocular pressure reducing effect of brinzolamide as adjunctive therapy to latanoprost.
    Li Yim JF; Montgomery DM
    Curr Med Res Opin; 2011 Aug; 27(8):1499-502. PubMed ID: 21651425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
    Feldman RM; Stewart RH; Stewart WC; Jia G; Smugar SS; Galet VA
    Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
    Kaback M; Scoper SV; Arzeno G; James JE; Hua SY; Salem C; Dickerson JE; Landry TA; Bergamini MV;
    Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.